Modifications of platelet retention in patients treated with pyridinolcarbamate. A preliminary report.
Pyridinolcarbamate (1 g daily for 30 days) was used for treating 9 patients with peripheral arteriopathies; 8 subjects had also diabetes mellitus in good metabolic control. A statistically significant decrease of platelet retention as measured by Salzman's method could be demonstrated.
D000328:Adult; D000368:Aged; D002219:Carbamates / Q000494:pharmacology*; D003925:Diabetic Angiopathies / Q000097:blood / Q000188:drug therapy; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010974:Platelet Aggregation / Q000187:drug effects*; D011727:Pyridinolcarbamate / Q000494:pharmacology* / Q000627:therapeutic use
D002219:Carbamates; D011727:Pyridinolcarbamate